Literature DB >> 18991056

An analysis of complex chromosomal aberrations in seven cases of myelodysplastic syndromes by M-FISH and whole chromosome painting.

Jian-Yong Li1, Bing Xiao2, Li-Juan Chen2, Jin-Lan Pan3, Wei Xu2, Hai-Rong Qiu2, Li Li2, Yong-Quan Xue3.   

Abstract

Complex chromosomal aberrations (CCAs) can be detected in a substantial proportion of myelodysplastic syndrome (MDS). Comprehensive analysis of the chromosomal rearrangements in these CCAs has been hampered by the limitations of conventional cytogenetics (CC). Multiplex fluorescence in situ hybridization (M-FISH) is a new generation FISH technique which allows simultaneous identification of all the 24 human chromosomes. So it is very useful in clarifying CCAs, identifying cryptic interchromosomal rearrangements and characterizing marker chromosomes. But it also has some limitations. We used M-FISH and whole chromosome painting (WCP) to accurately refine the CCAs revealed by R-banding CC in seven cases with MDS. The composition and origin of 6 kinds of marker chromosomes, nine kinds of chromosomes with additional material undetermined and five kinds of derivative chromosomes undefined by CC were defined after M-FISH analysis. Four kinds of cryptic translocations overlooked by CC were found on derivative chromosomes and previously normal appearing chromosomes. In addition, M-FISH revealed some nonrandom aberrations which most frequently involved chromosome 17 (5/7) and -5/5q-(4/7). Fluorescence flaring is a main factor leading to misinterpretations. Some misclassified and missed chromosomal aberrations by M-FISH were corrected by WCP. M-FISH is a powerful molecular cytogenetic tool in clarification of CCAs. Complementary WCP can further identify misclassified and missed chromosomal aberrations by M-FISH. CC in combination with molecular cytogenetic techniques including M-FISH and WCP can more precisely unravel CCAs.

Entities:  

Mesh:

Year:  2008        PMID: 18991056     DOI: 10.1007/s12185-008-0195-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

1.  Limitations of chromosome classification by multicolor karyotyping.

Authors:  C Lee; D Gisselsson; C Jin; A Nordgren; D O Ferguson; E Blennow; J A Fletcher; C C Morton
Journal:  Am J Hum Genet       Date:  2001-02-19       Impact factor: 11.025

2.  Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.

Authors:  Heidi Van Limbergen; Bruce Poppe; Lucienne Michaux; Christian Herens; Jill Brown; Luc Noens; Zwi Berneman; Robrecht De Bock; Anne De Paepe; Frank Speleman
Journal:  Genes Chromosomes Cancer       Date:  2002-01       Impact factor: 5.006

Review 3.  Human centromeric DNAs.

Authors:  C Lee; R Wevrick; R B Fisher; M A Ferguson-Smith; C C Lin
Journal:  Hum Genet       Date:  1997-09       Impact factor: 4.132

Review 4.  Cytogenetics of myelodysplastic syndromes.

Authors:  P Fenaux; P Morel; J L Lai
Journal:  Semin Hematol       Date:  1996-04       Impact factor: 3.851

5.  Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.

Authors:  Emmanuelle Barouk-Simonet; Valérie Soenen-Cornu; Christophe Roumier; Alain Cosson; Jean-Luc Laï; Pierre Fenaux; Claude Preudhomme
Journal:  Cancer Genet Cytogenet       Date:  2005-03

6.  Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

Authors:  C Schoch; T Haferlach; D Haase; C Fonatsch; H Löffler; B Schlegelberger; P Staib; M C Sauerland; A Heinecke; T Büchner; W Hiddemann
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

7.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

8.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.